Pomegra
Sunlight AI launched with a $17.4M seed round led by Basis Set Ventures to cut administrative costs for independent physician practices in October 2026.
Key Takeaways
- Sunlight AI announced a $17.4M seed round on October 19, 2026, led by Basis Set Ventures.
- It pairs practice-management software, AI and human staff to run billing, collections and scheduling.
- Valuation was not disclosed. The company is based in New York and Miami.
Lead
Sunlight AI came out of stealth on October 19, 2026 with a $17.4 million seed round led by Basis Set Ventures. The company, founded by Nayya Health founder Sina Chehrazi, sells an operating layer that takes over the business side of independent medical practices. Its pitch is lower administrative cost per encounter, better collections and more patient capacity, without the physician giving up ownership or clinical control. The company has offices in New York and Miami.
Who Else Is Backing Sunlight AI?
Beyond the lead, the round includes Sofeon Ventures, Social Leverage, Actions Capital, Overlook Ventures and Early Light Ventures. Angels and family offices also took part, among them Chris Hubbell, Tilli Bannett, Dara Rahimzadeh and Frank Williams, founder of Evolent Health. The company has not disclosed a valuation.
A seed round of this size is large for a company with no public customer roster. The investor list leans toward operators and generalist funds rather than a healthcare-only syndicate, which suggests the thesis is as much about services economics as about software.
What Does Sunlight AI Actually Sell?
Sunlight AI sells a bundled service that replaces the five or six vendors an independent practice typically juggles for billing, scheduling, collections and daily operations. The bundle combines practice-management infrastructure, human expertise and AI. The humans matter: this is closer to an outsourced back office than to a self-serve software tool.
The company also uses arbitration to recover payments from insurers, and its first arbitration clients are named in the launch materials. It has acquired Bradford Medical Associates, a practice, which gives it a working site to run its own system. Buying a practice to prove the model is a capital-intensive approach, and the seed money will show how far it can stretch.
The product displaces the fragmented set of billing companies, scheduling tools and part-time office managers that independent practices stitch together today. It also competes, indirectly, with the offer from hospitals and private equity roll-ups: sell the practice and let someone else handle operations.
Why Are Independent Practices Under Pressure?
Independent practices face rising costs and flat reimbursement, and consolidation has followed. Hospitals and corporate buyers acquired more than 85,000 practices between 2018 and 2026, and only 18% of physicians remain independent, according to a PAI-Avalere report cited by the company. Practice operating expenses rose 11% in 2025, and the company says Medicare physician payments have fallen 30% since 2001.
Those figures frame the market as a defensive one. Practices that cannot cut overhead sell, and the buyers tend to raise prices: hospital acquisitions correlate with physician price increases of 15.1% within two years, per the figures the company cites. Those numbers come from the company's own launch materials, and the causal story is simplified. Practices also sell for reasons of retirement, capital and negotiating power with insurers that software cannot fix.
What Is the Founder's Stake in This?
Chehrazi previously founded Nayya Health, a benefits-navigation company that serves more than 5 million employees. His father, Barry Chehrazi, is an independent neurosurgeon and a founding member of Sunlight AI's advisory board. "Physicians need more time to see patients and make clinical decisions, and less time dedicated to operational overhead," Chehrazi said in the announcement.
What Comes Next for Sunlight AI?
The open question is unit economics. A model that mixes software with human staff and owned practices has lower margins than pure software, and investors will want evidence that AI reduces headcount per encounter over time. The undisclosed valuation and the absence of published customer counts or revenue leave that unproven.
Two scenarios are plausible. If collections improve and cost per encounter falls at Bradford and the arbitration clients, the company can sign more independent groups and pitch itself as an alternative to selling out. If results are uneven, the acquisition-heavy approach could tie up capital before the next round.
Outlook
Sunlight AI enters a crowded revenue-cycle and practice-management market with $17.4 million, a lead investor in Basis Set Ventures and a thesis built on the shrinking share of independent physicians. The next signals to watch are customer counts, collections data and whether it buys more practices. A Series A would be the first real test of whether the bundled model scales.
